Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
ENGASE encodes a cytosolic enzyme which catalyzes the hydrolysis of peptides and proteins with mannose modifications to produce free oligosaccharides. Zusätzlich bieten wir Ihnen ENGASE Antikörper (16) und ENGASE Proteine (4) und viele weitere Produktgruppen zu diesem Protein an.
Showing 2 out of 6 products:
In patients with autosomal dominant polycystic kidney disease, urinary NAGase was correlated with urinary ET-1 (zeige EDN1 ELISA Kits) which was inversely associated with eGFR (zeige EGFR ELISA Kits) and positively correlated with total kidney volume.
Serological N-acetyl-glucosaminidase (zeige NAGLU ELISA Kits), telomere length, and the UCP2 (zeige UCP2 ELISA Kits)-886G>A variant are independent risk factors for type 2 diabetes.
As the generation of the bulk of fOS is unaffected by co-down regulation of Ngly1p and Engase1p, alternative quantitatively important mechanisms must underlie the liberation of these fOS from either LLO or glycoproteins during protein N-glycosylation.
O-GlcNAcase expression is increased in erythrocytes from both individuals with pre-diabetes and individuals with less well-controlled diabetes.
involved in processing of free oligosaccharides in the cytosol; identification of the gene encoding human cytosolic ENGase
endo-beta-n-acetylglucosaminidase present in the synovial fluid of rheumatoid arthritis patients, may contribute to the depletion of glycosaminoglycans from cartilage allowing the invasion of synovial cells
identification of O-GlcNAcase as a caspase-3 substrate with a novel caspase-3 cleavage site and provide insight about O-GlcNAcase regulation during apoptosis.
These observations strongly suggest that the Ngly1 (zeige NGLY1 ELISA Kits)- or Ngly1 (zeige NGLY1 ELISA Kits)/Engase-deficient mice could serve as a valuable animal model for studies related to the pathogenesis of the NGLY1 (zeige NGLY1 ELISA Kits)-deficiency, and that cytoplasmic ENGase represents one of the potential therapeutic targets for this genetic disorder.
ENGase efficiently hydrolyzes phosphorylated oligosaccharides that are larger than Man4GlcNAc2-P, generating GlcNAc-1-P and neutral Gn1-type free oligosaccharides.
This gene encodes a cytosolic enzyme which catalyzes the hydrolysis of peptides and proteins with mannose modifications to produce free oligosaccharides.
, Di-N-acetylchitobiosyl beta-N-acetylglucosaminidase
, Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase
, Cytosolic endo-beta-N-acetylglucosaminidase